ROS1 and non-small cell lung carcinoma: ALK and ROS1 rearrangements occur in 3–8% and 0.9‐2.6% of the overall NSCLC population, mostly on adenocarcinomas, with higher prevalence in nonsmokers, younger age and early‐stage brain metastasis.124, 172